Third first-in-human cancer treatment trial to open at U of M in last two months MINNEAPOLIS, MN- October 21, 2019 – A new cancer clinical trial has opened at the M Health Fairview University of Minnesota Medical Center that leverages the groundbreaking research...
Mark Terry of BioSpace writes: Pfizer announced results from its Phase III clinical trial, JADE MONO-1, of abrocitinib in moderate to severe atopic dermatitis. The drug met all the co-primary and key secondary endpoints related to skin clearance and itch relief...
Key Points Question At birth, are the risks of sensitization to cow’s milk formula and food allergy decreased by avoiding or by supplementing with cow’s milk formula? Findings In this randomized clinical trial involving 312 newborns, risks of sensitization to cow’s...
NEW YORK, Oct. 21, 2019 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced the completion of patient...
— Late-breaker abstract, “A North American Randomized Controlled Trial (RCT) of Terlipressin plus Albumin for the Treatment of Hepatorenal Syndrome Type 1 (HRS-1)” — STAINES-UPON-THAMES, United Kingdom, Oct. 21, 2019 /PRNewswire/...
Email
Text